These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23650191)

  • 1. Assessing neuropsychological impairment using Reitan and Wolfson's screening battery.
    Preiss J; Preiss M
    Arch Clin Neuropsychol; 2013 Aug; 28(5):492-8. PubMed ID: 23650191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for neuropsychological impairment in children using Reitan and Wolfson's preliminary neuropsychological test battery.
    Vanderslice-Barr JL; Lynch JK; McCaffrey RJ
    Arch Clin Neuropsychol; 2008 May; 23(3):243-9. PubMed ID: 18343088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for neuropsychological impairment using Reitan and Wolfson's preliminary neuropsychological test battery.
    Horwitz JE; Lynch JK; McCaffrey RJ; Fisher JM
    Arch Clin Neuropsychol; 2008 Jul; 23(4):393-8. PubMed ID: 18395407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for interpretation disparities of Halstead-Reitan neuropsychological battery performances in a litigating sample.
    Yantz CL; Gavett BE; Lynch JK; McCaffrey RJ
    Arch Clin Neuropsychol; 2006 Dec; 21(8):809-17. PubMed ID: 17023140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor structure of the Halstead-Reitan neuropsychological battery: a review and integration.
    Ross SA; Allen DN; Goldstein G
    Appl Neuropsychol Adult; 2013; 20(2):120-35. PubMed ID: 23397998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of serial testing in evaluating the need for comprehensive neuropsychological testing of adults.
    Reitan RM; Wolfson D
    Appl Neuropsychol; 2008; 15(1):21-32. PubMed ID: 18443937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the Halstead-Reitan Battery to diagnose brain damage: a comparison of the predictive power of traditional techniques to Rohling's Interpretive Method.
    Rohling ML; Williamson DJ; Miller LS; Adams RL
    Clin Neuropsychol; 2003 Nov; 17(4):531-43. PubMed ID: 15168917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of psychotic and substance abuse patients with or without head injury on the Halstead-Reitan Battery.
    Collingwood LM; Harrell EH
    Appl Neuropsychol; 1999; 6(2):88-95. PubMed ID: 10379414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial testing of older children as a basis for recommending comprehensive neuropsychological evaluation.
    Reitan RM; Wolfson D
    Appl Neuropsychol; 2008; 15(1):11-20. PubMed ID: 18443936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of brain injury severity by subscales of the alternative impairment index.
    Horton AM
    Int J Neurosci; 2000 Nov; 105(1-4):97-100. PubMed ID: 11069050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the ANAM General Neuropsychological Screening Battery (ANAM GNS) for detecting neurocognitive impairment in a mixed clinical sample.
    Woodhouse J; Heyanka DJ; Scott J; Vincent A; Roebuck-Spencer T; Domboski-Davidson K; O'Mahar K; Adams R
    Clin Neuropsychol; 2013; 27(3):376-85. PubMed ID: 23368639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raw, demographically altered, and composite Halstead-Reitan Battery data in the evaluation of adult victims of nonimpact acceleration forces in motor vehicle accidents.
    Sweeney JE
    Appl Neuropsychol; 1999; 6(2):79-87. PubMed ID: 10379413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single versus composite score discriminative validity with the Halstead-Reitan Battery and the Stroop Test in mild brain injury.
    Rojas DC; Bennett TL
    Arch Clin Neuropsychol; 1995 Mar; 10(2):101-10. PubMed ID: 14589732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the binomial distribution to predict impairment: application in a nonclinical sample.
    Axelrod BN; Wall JR; Estes BW
    Appl Neuropsychol; 2008; 15(3):170-5. PubMed ID: 18726737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-validation of the General Neuropsychological Deficit Scale (GNDS).
    Wolfson D; Reitan RM
    Arch Clin Neuropsychol; 1995 Mar; 10(2):125-31. PubMed ID: 14589734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-validation of Reitan and Wolfson's Neuropsychological Deficit Scales.
    Sherer M; Adams RL
    Arch Clin Neuropsychol; 1993 Oct; 8(5):429-35. PubMed ID: 14589712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease.
    Kaszás B; Kovács N; Balás I; Kállai J; Aschermann Z; Kerekes Z; Komoly S; Nagy F; Janszky J; Lucza T; Karádi K
    Parkinsonism Relat Disord; 2012 Jun; 18(5):553-6. PubMed ID: 22405839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological assessment of battered women: a pilot study.
    Deering C; Templer DI; Keller J; Canfield M
    Percept Mot Skills; 2001 Jun; 92(3 Pt 1):682-6. PubMed ID: 11453193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The operating characteristics of the major HRNES-R measures.
    Russell EW
    Arch Clin Neuropsychol; 2004 Dec; 19(8):1043-61. PubMed ID: 15533696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.